Investors Are Watching: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Engility Holdings, Inc. (NYSE:EGL), Sapiens International Corporation N.V. (NASDAQ:SPNS),

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced that it will host a conference call on Thursday, March 10, 2016 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter and year ended December 31, 2015.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) belongs to Healthcare sector. Its weekly performance is -6.67%. On last trading day company shares ended up at $0.70. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) distance from 50-day simple moving average (SMA50) is 8.14%.

On 3 February, Engility Holdings, Inc. (NYSE:EGL) announced financial results for the fourth quarter and full year ended December 31, 2015. Total revenue for the fourth quarter of 2015 was $537 million. GAAP operating loss was $262 million. GAAP net loss attributable to Engility was $239 million, or $6.53 per diluted share. Both GAAP operating loss and net loss reflect a $292 million non-cash goodwill impairment charge.

Engility Holdings, Inc. (NYSE:EGL) shares increased 8.22% in last trading session and ended the day at $17.24. EGL Gross Margin is 15.00% and its return on assets is 0.30%. Engility Holdings, Inc. (NYSE:EGL) quarterly performance is -51.26%.

On 29 February, Sapiens International Corporation N.V. (NASDAQ:SPNS) announced that it won two XCelent awards from Celent in the “advanced technology” and “breadth of functionality” categories for its Sapiens IDIT Policy Administration System for property and casualty (P&C)/general insurance (GI) markets. Celent, a research and consulting firm, analyzed more than 40 policy administration systems available to insurers in the EMEA region in 2015.

On 04 March, Sapiens International Corporation N.V. (NASDAQ:SPNS) shares fell -0.76% and was closed at $11.73. SPNS EPS growth in last 5 year was 7.90%. Sapiens International Corporation N.V. (NASDAQ:SPNS) year to date (YTD) performance is 15.00%.

OXiGENE Inc (NASDAQ:OXGN) had its target price trimmed by S&P Equity Research from $0.64 to $0.58 in a report issued on Friday morning, Marketbeat reports.

OXiGENE, Inc. (NASDAQ:OXGN) shares advanced 8.46% in last trading session and ended the day at $0.64. OXGN return on assets is -37.50%. OXiGENE, Inc. (NASDAQ:OXGN) quarterly performance is -30.68%.

On 1 March, Linn Co, LLC (NASDAQ:LNCO) announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late Filing with regard to its Annual Report on Form 10-K for the year ended December 31, 2015 to allow additional time to complete its financial statements and related disclosures. Additional information can be found in LINN’s and LinnCo’s Forms 12b-25 on file with the SEC.

Linn Co, LLC (NASDAQ:LNCO) shares increased 88.67% in last trading session and ended the day at $0.75. LNCO return on assets is -202.30%. Linn Co, LLC (NASDAQ:LNCO) quarterly performance is -50.35%.

Leave a Reply

Your email address will not be published. Required fields are marked *